We represented BioMatrix Specialty Pharmacy, a comprehensive, nationwide specialty pharmacy services and digital health technology solutions provider, in its acquisition of City Drugs, a New York City-based specialty pharmacy that specializes in the treatment of complex medical conditions including hepatitis, oncology, auto-immune diseases, and gastroenterology. Terms of the transaction were not disclosed.
BioMatrix Acquires City Drugs
You Also May Be Interested In:
Successful Defense of National Home Healthcare Provider in Appealing $18 Million Extrapolated Overpayment Resulting from UPIC Audit
We successfully defended a national home healthcare provider in appealing an $18 million extrapolated overpayment resulting from a UPIC audit.
Advise a public university system on compliance with the rules associated with grants and contracts from NIH, NSF, and the Department of Defense